Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Steele Richard GSVP - General Counsel |  MCOMOODYS CORP /DE/Open-market sale · 10b5-1 plan | SELL | $74K 158 sh | May 4, 2026 |
| 8 | Hooker David StevensDirector |  NPBNORTHPOINTE BANCSHARES INCOpen-market sale · 10b5-1 plan | SELL | $125K 7,000 sh | May 4, 2026 traded May 1, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $187K 800 sh | May 4, 2026 traded May 1, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $213K 932 sh | May 4, 2026 traded May 1, 2026 |
| 6 | Skinner Todd C.President, International |  TRUTransUnionOpen-market sale · 10b5-1 plan | SELL | $36K 500 sh | May 4, 2026 traded May 1, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $181K 780 sh | May 4, 2026 traded May 1, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $85K 370 sh | May 4, 2026 traded May 1, 2026 |
| 6 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $136K 600 sh | May 4, 2026 traded May 1, 2026 |
| 5 | Hooker David StevensDirector | NPBNORTHPOINTE BANCSHARES INC Open-market sale · 10b5-1 plan | SELL | $8,910 500 sh | May 4, 2026 traded May 1, 2026 |
| 4 | Badjate PramodPresident & GM, NFB |  NTGRNETGEAR, INC.Open-market sale · 10b5-1 plan | SELL | $76K 3,000 sh | May 4, 2026 traded May 1, 2026 |
| 3 | Reardon AndrewCLO & Secretary | LGNDLIGAND PHARMACEUTICALS INC Open-market sale · 10b5-1 plan | SELL | $23K 98 sh | May 4, 2026 traded May 1, 2026 |
| 52 | Baker JeffPrincipal Accounting Officer | CRWVCoreWeave, Inc. Open-market sale | SELL | $729K 6,760 sh | May 1, 2026 traded Apr 29, 2026 |
| 44 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $3.21M 28.1K sh | May 1, 2026 traded Apr 29, 2026 |
| 41 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $803K 7,029 sh | May 1, 2026 traded Apr 29, 2026 |
| 41 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $846K 7,359 sh | May 1, 2026 traded Apr 29, 2026 |
| 38 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $211K 1,839 sh | May 1, 2026 traded Apr 29, 2026 |
| 37 | Young Tobi M.Director |  HALHALLIBURTON COOpen-market sale | SELL | $235K 5,625 sh | May 1, 2026 traded Apr 30, 2026 |
| 34 | Schwartz Richard ToddDirector, Chief Executive Officer |  RSIRush Street Interactive, Inc.Open-market sale · 10b5-1 plan | SELL | $1.56M 55.6K sh | May 1, 2026 traded May 1, 2026 |
| 34 | Schwartz Richard ToddDirector, Chief Executive Officer | RSIRush Street Interactive, Inc. Open-market sale · 10b5-1 plan | SELL | $1.56M 55.6K sh | May 1, 2026 traded May 1, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $418K 3,754 sh | May 1, 2026 traded Apr 29, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $883K 7,796 sh | May 1, 2026 traded Apr 29, 2026 |
| 33 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $991K 8,834 sh | May 1, 2026 traded Apr 29, 2026 |
| 32 | Cashman SteveChief Business Officer |  BFLYButterfly Network, Inc.Open-market sale | SELL | $724K 147.5K sh | May 1, 2026 traded Apr 29, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $105K 939 sh | May 1, 2026 traded Apr 29, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $221K 1,950 sh | May 1, 2026 traded Apr 29, 2026 |
| 30 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $248K 2,208 sh | May 1, 2026 traded Apr 29, 2026 |
| 28 | Sloan SheldonChief Medical Officer |  SYRESpyre Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $377K 5,059 sh | May 1, 2026 traded May 1, 2026 |
| 28 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $764K 10.4K sh | May 1, 2026 traded May 1, 2026 |
| 28 | Larabee Brian KeithSVP & GM - EMS |  ROGROGERS CORPOpen-market sale | SELL | $113K 830 sh | May 1, 2026 traded May 1, 2026 |
| 27 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.48M 21.3K sh | May 1, 2026 traded May 1, 2026 |
| 27 | Sloan SheldonChief Medical Officer | SYRESpyre Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $1.39M 19.7K sh | May 1, 2026 traded May 1, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $57K 520 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Young Tobi M.Director | HALHALLIBURTON CO Open-market sale | SELL | $21K 500 sh | May 1, 2026 traded Apr 30, 2026 |
| 26 | Schwartz Richard ToddDirector, Chief Executive Officer | RSIRush Street Interactive, Inc. Open-market sale · 10b5-1 plan | SELL | $1.33M 47.2K sh | May 1, 2026 traded May 1, 2026 |
| 26 | Sullivan Christopher RyanChief Financial Officer |  AVTXAvalo Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $111K 8,458 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $112K 8,457 sh | May 1, 2026 traded Apr 30, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $190K 1,760 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $226K 2,080 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $51K 460 sh | May 1, 2026 traded Apr 29, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $203K 1,840 sh | May 1, 2026 traded Apr 29, 2026 |